BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 30/01/1996

Bio-Components, Inc. Faces Potential Revocation of FDA Licenses

The FDA is offering a hearing on a proposal to revoke Bio-Components, Inc.'s licenses due to noncompliance with federal biologics regulations, following significant and continued issues with the company's manufacturing processes.

Source: Federal Register — Food and Drug AdministrationOpen original release →